# Newsletter

```json
{
  "title": "LAI Intelligence Weekly – December 8, 2025",
  "intro": "This week's intelligence highlights critical developments across the hemophilia treatment landscape, regulatory milestones, and strategic marketing initiatives. Pfizer advances its competitive positioning with new Hympavzi data, while safety concerns emerge around Takeda's rare disease portfolio. Pharmaceutical leaders continue aggressive direct-to-consumer campaigns and explore novel awareness strategies for antimicr

*Newsletter générée par Vectora Inbox – Powered by Amazon Bedrock*
